{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:54:21Z","timestamp":1780592061874,"version":"3.54.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["977505"],"award-info":[{"award-number":["977505"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human T-lymphotropic virus 1 (HTLV-1) infection may lead to the development of Adult T-cell leukemia\/lymphoma (ATLL). To further elucidate the pathophysiology of this aggressive CD4+ T-cell malignancy, we have performed an integrated systems biology approach to analyze previous transcriptome datasets focusing on differentially expressed miRNAs (DEMs) in peripheral blood of ATLL patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Datasets GSE28626, GSE31629, GSE11577 were used to identify ATLL-specific DEM signatures. The target genes of each identified miRNA were obtained to construct a protein-protein interactions network using STRING database. The target gene hubs were subjected to further analysis to demonstrate significantly enriched gene ontology terms and signaling pathways. Quantitative reverse transcription Polymerase Chain Reaction (RTqPCR) was performed on major genes in certain pathways identified by network analysis to highlight gene expression alterations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>High-throughput in silico analysis revealed 9 DEMs <jats:italic>hsa-let-7a, hsa-let-7g, hsa-mir-181b, hsa-mir-26b, hsa-mir-30c, hsa-mir-186, hsa-mir-10a, hsa-mir-30b, and hsa-let-7f<\/jats:italic> between ATLL patients and healthy donors. Further analysis revealed the first 5 of DEMs were directly associated with previously identified pathways in the pathogenesis of HTLV-1. Network analysis demonstrated the involvement of target gene hubs in several signaling cascades, mainly in the MAPK pathway. RT-qPCR on human ATLL samples showed significant upregulation of <jats:italic>EVI1<\/jats:italic>, <jats:italic>MKP1<\/jats:italic>, <jats:italic>PTPRR,<\/jats:italic> and JNK gene vs healthy donors in MAPK\/JNK pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The results highlighted the functional impact of a subset dysregulated microRNAs in ATLL on cellular gene expression and signal transduction pathways. Further studies are needed to identify novel biomarkers to obtain a comprehensive mapping of deregulated biological pathways in ATLL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13027-021-00390-3","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T19:02:36Z","timestamp":1624993356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK\/JNK signal transduction pathway in Adult T-cell leukemia\/lymphoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Shahrzad","family":"Shadabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nargess","family":"Delrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ehteshami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Habibian-Sezavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Pourrezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Madihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Ostadali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foruhar","family":"Akhgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shayeghpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cobra","family":"Razavi Pashabayg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed-Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Mohammad","family":"Jazayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"1","key":"390_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CRM Bangham","year":"2018","unstructured":"Bangham CRM, Human T. Cell leukemia virus type 1: persistence and pathogenesis. Ann Rev Immunol. 2018;36(1):43\u201371.","journal-title":"Ann Rev Immunol."},{"key":"390_CR2","doi-asserted-by":"publisher","unstructured":"Gessain A, Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3(388). https:\/\/doi.org\/10.3389\/fmicb.2012.00388.","DOI":"10.3389\/fmicb.2012.00388"},{"issue":"3","key":"390_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3960\/jslrt.20019","volume":"60","author":"K Kataoka","year":"2020","unstructured":"Kataoka K, Koya J. Clinical application of genomic aberrations in adult T-cell leukemia\/lymphoma. J Clin Exp Hematop. 2020;60(3):66\u201372.","journal-title":"J Clin Exp Hematop."},{"issue":"39","key":"390_CR4","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","volume":"24","author":"GP Taylor","year":"2005","unstructured":"Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy. Oncogene. 2005;24(39):6047\u201357.","journal-title":"Oncogene."},{"key":"390_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fmicb.2020.00979","volume":"11","author":"JI Yasunaga","year":"2020","unstructured":"Yasunaga JI. Strategies of human T-cell leukemia virus type 1 for persistent infection: implications for leukemogenesis of adult T-cell leukemia-lymphoma. Front Microbiol. 2020;11:979.","journal-title":"Front Microbiol."},{"key":"390_CR6","volume-title":"Adult T cell leukemia","author":"C Durer","year":"2020","unstructured":"Durer C, Babiker HM. Adult T cell leukemia. Treasure Island, FL: StatPearls Publishing Copyright \u00a9 2020. StatPearls Publishing LLC.; 2020."},{"key":"390_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-981-10-5765-6_9","volume":"1018","author":"CP Chan","year":"2017","unstructured":"Chan CP, Kok KH, Jin DY. Human T-cell leukemia virus type 1 infection and adult T-cell leukemia. Adv Exp Med Biol. 2017;1018:147\u201366.","journal-title":"Adv Exp Med Biol."},{"key":"390_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-030-57362-1_10","volume":"217","author":"CZ Giam","year":"2021","unstructured":"Giam CZ. HTLV-1 replication and adult T cell leukemia development. Recent Results Cancer Res. 2021;217:209\u201343.","journal-title":"Recent Results Cancer Res."},{"issue":"6","key":"390_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.coviro.2013.08.010","volume":"3","author":"M Matsuoka","year":"2013","unstructured":"Matsuoka M, Yasunaga J-I. Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor. Curr Opin Virol. 2013;3(6):684\u201391.","journal-title":"Curr Opin Virol."},{"issue":"2","key":"390_CR10","doi-asserted-by":"publisher","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J-I, Zhao T, Yoshida M, Miyazato P, Takai K, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLOS Pathog. 2011;7(2):e1001274.","journal-title":"PLOS Pathog."},{"issue":"5","key":"390_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nm0507-527","volume":"13","author":"T Ohsugi","year":"2007","unstructured":"Ohsugi T, Kumasaka T, Okada S, Urano T. The tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells. Nat Med. 2007;13(5):527\u20138.","journal-title":"Nat Med."},{"key":"390_CR12","doi-asserted-by":"publisher","first-page":"614940","DOI":"10.3389\/fmicb.2020.614940","volume":"11","author":"S Aghajanian","year":"2020","unstructured":"Aghajanian S, Teymoori-Rad M, Molaverdi G, Mozhgani S-H. Immunopathogenesis and cellular interactions in human T-cell leukemia virus type 1 associated myelopathy\/tropical spastic paraparesis. Front Microbiol. 2020;11:614940.","journal-title":"Front Microbiol."},{"issue":"39","key":"390_CR13","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","volume":"24","author":"R Grassmann","year":"2005","unstructured":"Grassmann R, Aboud M, Jeang K-T. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 2005;24(39):5976\u201385.","journal-title":"Oncogene."},{"issue":"4","key":"390_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/pathogens8040290","volume":"8","author":"S Fochi","year":"2019","unstructured":"Fochi S, Ciminale V, Trabetti E, Bertazzoni U, D\u2019Agostino DM, Zipeto D, et al. NF-\u03baB and microRNA deregulation mediated by HTLV-1 tax and HBZ. Pathogens. 2019;8(4):290.","journal-title":"Pathogens."},{"issue":"6","key":"390_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/v8060161","volume":"8","author":"C-Z Giam","year":"2016","unstructured":"Giam C-Z, Semmes OJ. HTLV-1 infection and adult T-cell leukemia\/lymphoma\u2014A tale of two proteins: tax and HBZ. Viruses. 2016;8(6):161.","journal-title":"Viruses."},{"issue":"11","key":"390_CR16","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J-I, et al. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genetics. 2015;47(11):1304\u201315.","journal-title":"Nat Genetics."},{"issue":"4","key":"390_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ijc.20007","volume":"109","author":"S Takeda","year":"2004","unstructured":"Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J-I, Nosaka K, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004;109(4):559\u201367.","journal-title":"Int J Cancer."},{"issue":"11","key":"390_CR18","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"NA Gillet","year":"2011","unstructured":"Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, et al. The host genomic environment of the provirus determines the abundance of HTLV-1\u2013infected T-cell clones. Blood. 2011;117(11):3113\u201322.","journal-title":"Blood."},{"issue":"7","key":"390_CR19","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.3390\/v7072805","volume":"7","author":"R Moles","year":"2015","unstructured":"Moles R, Nicot C. The emerging role of miRNAs in HTLV-1 infection and ATLL pathogenesis. Viruses. 2015;7(7):4047\u201374.","journal-title":"Viruses."},{"key":"390_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fgene.2012.00295","volume":"3","author":"G Sampey","year":"2012","unstructured":"Sampey G, Van Duyne R, Currer R, Das R, Narayanan A, Kashanchi F. Complex role of microRNAs in HTLV-1 infections. Front Genetics. 2012;3:295.","journal-title":"Front Genetics."},{"issue":"5","key":"390_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.mam.2010.05.001","volume":"31","author":"K Ruggero","year":"2010","unstructured":"Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, Ciminale V, et al. Role of microRNAs in HTLV-1 infection and transformation. Mol Aspects Med. 2010;31(5):367\u201382.","journal-title":"Mol Aspects Med."},{"key":"390_CR22","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3389\/fmicb.2018.01686","volume":"9","author":"M Yamagishi","year":"2018","unstructured":"Yamagishi M, Fujikawa D, Watanabe T, Uchimaru K. HTLV-1-mediated epigenetic pathway to adult T-cell leukemia-lymphoma. Front Microbiol. 2018;9:1686.","journal-title":"Front Microbiol."},{"issue":"21","key":"390_CR23","doi-asserted-by":"publisher","first-page":"30258","DOI":"10.18632\/oncotarget.7162","volume":"7","author":"H Gazon","year":"2016","unstructured":"Gazon H, Belrose G, Terol M, Meniane J-C, Mesnard J-M, C\u00e9saire R, et al. Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients. Oncotarget. 2016;7(21):30258\u201375.","journal-title":"Oncotarget."},{"issue":"5","key":"390_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/cas.12126","volume":"104","author":"N Kitagawa","year":"2013","unstructured":"Kitagawa N, Ojima H, Shirakihara T, Shimizu H, Kokubu A, Urushidate T, et al. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Sci. 2013;104(5):543\u201351.","journal-title":"Cancer Sci."},{"issue":"3","key":"390_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12253-014-9750-5","volume":"20","author":"SY Kwon","year":"2014","unstructured":"Kwon SY, Lee JH, Kim B, Park JW, Kwon TK, Kang SH, et al. Complexity in regulation of microRNA machinery components in invasive breast carcinoma. Pathol Oncol Res. 2014;20(3):697\u2013705.","journal-title":"Pathol Oncol Res."},{"issue":"1","key":"390_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1742-4690-5-100","volume":"5","author":"K Pichler","year":"2008","unstructured":"Pichler K, Schneider G, Grassmann R. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology. 2008;5(1):100.","journal-title":"Retrovirology."},{"issue":"D1","key":"390_CR27","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y. Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucl Acids Res. 2020;48(D1):D127\u2013D31.","journal-title":"Nucl Acids Res."},{"issue":"11","key":"390_CR28","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res."},{"issue":"1","key":"390_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14(1):128.","journal-title":"BMC Bioinformatics."},{"issue":"1","key":"390_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucl Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucl Acids Res."},{"key":"390_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000490058","volume":"18","author":"S-H Mozhgani","year":"2018","unstructured":"Mozhgani S-H, Jahantigh HR, Rafatpanah H, Valizadeh N, Mohammadi A, Basharkhah S, et al. Interferon lambda family along with HTLV-1 proviral load, tax, and HBZ implicated in the pathogenesis of myelopathy\/tropical spastic paraparesis. Neurodegenerative Diseases. 2018;18:150\u20135.","journal-title":"Neurodegenerative Diseases."},{"issue":"1","key":"390_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12977-019-0508-8","volume":"16","author":"S-H Mozhgani","year":"2019","unstructured":"Mozhgani S-H, Piran M, Zarei-Ghobadi M, Jafari M, Jazayeri S-M, Mokhtari-Azad T, et al. An insight to HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis. Retrovirology. 2019;16(1):46.","journal-title":"Retrovirology."},{"issue":"7","key":"390_CR33","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1128\/JVI.02823-13","volume":"88","author":"K Ruggero","year":"2014","unstructured":"Ruggero K, Guffanti A, Corradin A, Sharma VK, De Bellis G, Corti G, et al. Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase. J Virol. 2014;88(7):3612\u201322.","journal-title":"J Virol."},{"issue":"1","key":"390_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","volume":"21","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers. Cancer Cell. 2012;21(1):121\u201335.","journal-title":"Cancer Cell."},{"issue":"21","key":"390_CR35","doi-asserted-by":"publisher","first-page":"8976","DOI":"10.1158\/0008-5472.CAN-08-0769","volume":"68","author":"ML Yeung","year":"2008","unstructured":"Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, et al. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res. 2008;68(21):8976\u201385.","journal-title":"Cancer Res."},{"issue":"20","key":"390_CR36","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1182\/blood-2008-11-189845","volume":"113","author":"M Bellon","year":"2009","unstructured":"Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood. 2009;113(20):4914\u20137.","journal-title":"Blood."},{"issue":"9","key":"390_CR37","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1371\/journal.pmed.0050184","volume":"5","author":"A Ramasamy","year":"2008","unstructured":"Ramasamy A, Mondry A, Holmes CC, Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLOS Medicine. 2008;5(9):e184.","journal-title":"PLOS Medicine."},{"issue":"1","key":"390_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbrc.2011.11.119","volume":"417","author":"Y Liu","year":"2012","unstructured":"Liu Y, Yin B, Zhang C, Zhou L, Fan J. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. Biochem Biophys Res Commun. 2012;417(1):371\u20135.","journal-title":"Biochem Biophys Res Commun."},{"issue":"5","key":"390_CR39","first-page":"317","volume":"3","author":"GO Nakajima","year":"2006","unstructured":"Nakajima GO, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki KEN, et al. Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics\u2014Proteomics. 2006;3(5):317.","journal-title":"Cancer Genomics\u2014Proteomics."},{"issue":"2","key":"390_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ijc.25336","volume":"128","author":"F-F Lan","year":"2011","unstructured":"Lan F-F, Wang H, Chen Y-C, Chan C-Y, Ng SS, Li K, et al. Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16INK4A. Int J Cancer. 2011;128(2):319\u201331.","journal-title":"Int J Cancer."},{"issue":"20","key":"390_CR41","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","volume":"18","author":"DM Miller","year":"2012","unstructured":"Miller DM, Thomas SD, Islam A, Muench D. Sedoris K. c-Myc and cancer metabolism. Clin Cancer Res. 2012;18(20):5546\u201353.","journal-title":"Clin Cancer Res."},{"key":"390_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2017.05.001","volume":"625","author":"J Li","year":"2017","unstructured":"Li J, Liang Y, Lv H, Meng H, Xiong G, Guan X, et al. miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway. Gene. 2017;625:1\u20139.","journal-title":"Gene."},{"issue":"4","key":"390_CR43","doi-asserted-by":"publisher","first-page":"e18409","DOI":"10.1371\/journal.pone.0018409","volume":"6","author":"S Liang","year":"2011","unstructured":"Liang S, He L, Zhao X, Miao Y, Gu Y, Guo C, et al. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLOS ONE. 2011;6(4):e18409.","journal-title":"PLOS ONE."},{"issue":"1","key":"390_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12935-014-0073-0","volume":"14","author":"JR Dobson","year":"2014","unstructured":"Dobson JR, Taipaleenm\u00e4ki H, Hu Y-J, Hong D, van Wijnen AJ, Stein JL, et al. hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV\/CCN3. Cancer Cell Int. 2014;14(1):73.","journal-title":"Cancer Cell Int."},{"issue":"12","key":"390_CR45","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1158\/1541-7786.MCR-08-0167","volume":"6","author":"X Agirre","year":"2008","unstructured":"Agirre X, Jim\u00e9nez-Velasco A, San Jos\u00e9-En\u00e9riz E, Garate L, Bandr\u00e9s E, Cordeu L, et al. Down-regulation of &lt;em&gt;hsa-miR-10a&lt;\/em&gt; in chronic myeloid leukemia CD34&lt;sup&gt;+&lt;\/sup&gt; Cells increases USF2-mediated cell growth. Mol Cancer Res. 2008;6(12):1830.","journal-title":"Mol Cancer Res."},{"issue":"9","key":"390_CR46","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/ijc.24183","volume":"124","author":"S Veerla","year":"2009","unstructured":"Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H, et al. MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer. 2009;124(9):2236\u201342.","journal-title":"Int J Cancer."},{"issue":"1","key":"390_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yexmp.2013.05.001","volume":"95","author":"J Hudson","year":"2013","unstructured":"Hudson J, Duncavage E, Tamburrino A, Salerno P, Xi L, Raffeld M, et al. Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma. Exp Mol Pathol. 2013;95(1):62\u20137.","journal-title":"Exp Mol Pathol."},{"issue":"13","key":"390_CR48","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.7150\/ijbs.25352","volume":"14","author":"R Wang","year":"2018","unstructured":"Wang R, Bao H, Zhang S, Li R, Chen L, Zhu Y. miR-186-5p promotes apoptosis by targeting IGF-1 in SH-SY5Y OGD\/R model. Int J Biol Sci. 2018;14(13):1791\u20139.","journal-title":"Int J Biol Sci."},{"issue":"1","key":"390_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13027-020-00343-2","volume":"16","author":"A Nascimento","year":"2021","unstructured":"Nascimento A, Valad\u00e3o de Souza DR, Pess\u00f4a R, Pietrobon AJ, Nukui Y, Pereira J, et al. Global expression of noncoding RNome reveals dysregulation of small RNAs in patients with HTLV-1\u2013associated adult T-cell leukemia: a pilot study. Infectious Agents Cancer. 2021;16(1):4.","journal-title":"Infectious Agents Cancer."},{"issue":"3","key":"390_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-020-2399-y","volume":"11","author":"D Verzella","year":"2020","unstructured":"Verzella D, Pescatore A, Capece D, Vecchiotti D, Ursini MV, Franzoso G, et al. Life, death, and autophagy in cancer: NF-\u03baB turns up everywhere. Cell Death Disease. 2020;11(3):210.","journal-title":"Cell Death Disease."},{"issue":"6861","key":"390_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/35104568","volume":"414","author":"G Tang","year":"2001","unstructured":"Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, et al. Inhibition of JNK activation through NF-\u03baB target genes. Nature. 2001;414(6861):313\u20137.","journal-title":"Nature."},{"issue":"1","key":"390_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/bbrc.1998.9256","volume":"250","author":"Y-J Bang","year":"1998","unstructured":"Bang Y-J, Kwon JH, Kang SH, Kim JW, Yang YC. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun. 1998;250(1):43\u20137.","journal-title":"Biochem Biophys Res Commun."},{"issue":"24","key":"390_CR53","doi-asserted-by":"publisher","first-page":"11933","DOI":"10.1158\/0008-5472.CAN-07-5185","volume":"67","author":"J Wang","year":"2007","unstructured":"Wang J, Zhou J-Y, Wu GS. ERK-dependent MKP-1\u2013mediated cisplatin resistance in human ovarian cancer cells. Cancer Res. 2007;67(24):11933\u201341.","journal-title":"Cancer Res."},{"issue":"1","key":"390_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1012-8","volume":"15","author":"J Munkley","year":"2015","unstructured":"Munkley J, Lafferty NP, Kalna G, Robson CN, Leung HY, Rajan P, et al. Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1\/2 signalling in prostate cancer cells. BMC Cancer. 2015;15(1):1\u201311.","journal-title":"BMC Cancer."},{"issue":"1","key":"390_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/onc.2012.29","volume":"32","author":"P Su","year":"2013","unstructured":"Su P, Lin Y, Huang R, Liao Y, Lee H, Wang H, et al. Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer. Oncogene. 2013;32(1):15\u201326.","journal-title":"Oncogene."},{"key":"390_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2005.09.020","volume":"368","author":"G Nucifora","year":"2006","unstructured":"Nucifora G, Laricchia-Robbio L, Senyuk V. EVI1 and hematopoietic disorders: history and perspectives. Gene. 2006;368:1\u201311.","journal-title":"Gene."},{"issue":"7","key":"390_CR57","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-06-2366","volume":"67","author":"M Nanjundan","year":"2007","unstructured":"Nanjundan M, Nakayama Y, Cheng KW, Lahad J, Liu J, Lu K, et al. Amplification of MDS1\/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer. Cancer Res. 2007;67(7):3074.","journal-title":"Cancer Res."},{"issue":"1","key":"390_CR58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-4690-5-76","volume":"5","author":"M Boxus","year":"2008","unstructured":"Boxus M, Twizere J-C, Legros S, Dewulf J-F, Kettmann R, Willems L. The HTLV-1 tax interactome. Retrovirology. 2008;5(1):76.","journal-title":"Retrovirology."},{"issue":"1","key":"390_CR59","first-page":"135","volume":"13","author":"X Xu","year":"1996","unstructured":"Xu X, Heidenreich O, Kitajima I, McGuire K, Li Q, Su B, et al. Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene. 1996;13(1):135\u201342.","journal-title":"Oncogene."},{"issue":"5","key":"390_CR60","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0092-8674(00)81447-6","volume":"93","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Christerson LB, Yamamoto Y, Kwak YT, Xu S, Mercurio F, et al. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell. 1998;93(5):875\u201384.","journal-title":"Cell."},{"issue":"6861","key":"390_CR61","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/35104560","volume":"414","author":"E De Smaele","year":"2001","unstructured":"De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, et al. Induction of gadd45\u03b2 by NF-\u03baB downregulates pro-apoptotic JNK signalling. Nature. 2001;414(6861):308\u201313.","journal-title":"Nature."},{"issue":"5","key":"390_CR62","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/sj.cdd.4401865","volume":"13","author":"S Papa","year":"2006","unstructured":"Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR, et al. The NF-\u03baB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differen. 2006;13(5):712\u201329.","journal-title":"Cell Death Differen."},{"issue":"5","key":"390_CR63","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.bbamcr.2011.02.002","volume":"1813","author":"S Nakachi","year":"2011","unstructured":"Nakachi S, Nakazato T, Ishikawa C, Kimura R, Mann DA, Senba M, et al. Human T-cell leukemia virus type 1 Tax transactivates the matrix metalloproteinase 7 gene via JunD\/AP-1 signaling. Biochim Biophys Acta Mol Cell Res. 2011;1813(5):731\u201341.","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"issue":"8","key":"390_CR64","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda \u00c1R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9(8):537\u201349.","journal-title":"Nat Rev Cancer."}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-021-00390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-021-00390-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-021-00390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T19:05:20Z","timestamp":1624993520000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-021-00390-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1186\/s13027-021-00390-3","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"3 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This work was approved by the Ethics Committee of Biomedical Research at Alborz University of Medical Sciences (IR.NIMAD.REC.1397.473)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"49"}}